HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pure red cell aplasia associated with CD20+ myeloma: complete remission with rituximab.

AuthorsChi-Chiu So, William W L Choi, Yok-Lam Kwong
JournalAnnals of hematology (Ann Hematol) Vol. 92 Issue 10 Pg. 1425-6 (Oct 2013) ISSN: 1432-0584 [Electronic] Germany
PMID23494205 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Rituximab
Topics
  • Adult
  • Antibodies, Monoclonal, Murine-Derived (therapeutic use)
  • Antigens, CD20 (metabolism)
  • Female
  • Humans
  • Multiple Myeloma (complications, drug therapy, metabolism)
  • Red-Cell Aplasia, Pure (drug therapy, etiology, metabolism)
  • Remission Induction
  • Rituximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: